Growth Metrics

Jaguar Health (JAGX) Return on Equity (2016 - 2025)

Jaguar Health (JAGX) has disclosed Return on Equity for 11 consecutive years, with 7.54% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 1154.0% to 7.54% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.54% through Dec 2025, up 1154.0% year-over-year, with the annual reading at 8.86% for FY2025, 1575.0% up from the prior year.
  • Return on Equity for Q4 2025 was 7.54% at Jaguar Health, up from 7.3% in the prior quarter.
  • The five-year high for Return on Equity was 7.54% in Q4 2025, with the low at 43.21% in Q4 2022.
  • Average Return on Equity over 5 years is 8.21%, with a median of 6.32% recorded in 2022.
  • The sharpest move saw Return on Equity tumbled -4006bps in 2022, then surged 2994bps in 2023.
  • Over 5 years, Return on Equity stood at 3.15% in 2021, then tumbled by -1272bps to 43.21% in 2022, then skyrocketed by 69bps to 13.27% in 2023, then soared by 70bps to 4.01% in 2024, then surged by 288bps to 7.54% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 7.54%, 7.3%, and 10.74% for Q4 2025, Q3 2025, and Q2 2025 respectively.